Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 891-894

  Doern, Gary V ^a   Ferraro, Mary Jane ^b   Brueggemann, Angela B ^a   Ruoff, Kathryn L ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G; TETRACYCLINE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS MITIS;

EID: 0029939123     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.891     Document Type: Article

References (15)

1. Bochud, P.-Y, P. Eggiman, T. Calandra, G. Van Melle, L. Saghafi, and P. Francioli. 1994. Bacteremia due to viridans streptococcus in neutropenic patients with cancer, clinical spectrum and risk factors. Clin. Infect. Dis. 18:25-31.
2. Bourgault, A. M., W. R. Wilson, and J. A. Washington II. 1979 Antimicrobial susceptibilities of species of vindans streptococci. J. Infect. Dis 140: 316-324.
3. Dajani, A. S., A. L. Bisno, and K. J. Chung. 1990. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 246:2919-2922
4. Henslee, J., B. Bostrom, D. Weidorf, N. Ramsay, P. McGlave, and J. Kersey. 1984. Streptococcal sepsis in bone marrow transplant patients. Lancet i:393.
5. Kern, W., E. Kurrle, and T. Schmeiser. 1990 Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 18:138-145.
6. Kern, W., K. Linzmeier, and E. Kurrle. 1989. Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis Infection 17:396-397.
7. McWhinney, P. H. M., S. H. Gillespie, C. C. Kibbler, A. V. Hoffbrand, and H. G. Prentice. 1991 Streptococcus mitis and ARDS in neutropenic patients. Lancet 337:429
8. McWhinney, P. H. M., S. Patel, R. A. Whiley, J. M. Hardie, S. H. Gillespie, and C. C. Kibbler. 1993. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob. Agents Chemother. 37:2493-2495.
9. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. Quinn, J. P., C. A. DiVincenzo, D. A. Lucks, R. L. Luskin, K. L. Shatzer, and S. A. Lerner. 1988. Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J. infect. Dis. 157:764-769.
12. Rapeport, K. B., J. A. Giron, and F. Rosner. 1986. Streptococcus mitis endocarditis. Arch. Intern. Med. 146:2361-2363
13. Roberts, R. B., A. G. Krieger, N. L. Schiller, and K. C. Gross. 1979. Viridans streptococcal endocarditis: the role of various species, including pyridoxaldcpendent streptococci. Rev. Infect. Dis. 1:955-961.
14. Ruoff, K. L. 1995. Streptococcus, p. 299-307. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yalken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
15. Venditti, M., P. Baiocchi, C. Santini, C. Brandimarte, P. Serra, G. Gentile, C. Girmenia, and P. Martino. 1989. Antimicrobial susceptibilities of strep-tococcus species that cause septicemia in neutropenic patients. Antimicrob. Agents Chemother. 33:580-582